NMPA Approval

Thymopolypeptides for Injection

Approval Number

国药准字H20003541

Registration Date

March 17, 2021

Previous Approval Numbers

国药准字H20003541

Drug Information

Generic Name

注射用胸腺肽

Dosage Form

注射剂

Strength

20mg

Drug Type

化学药品

Registration Date

March 17, 2021

Company Address

杭州市西湖区花牌楼160号

Company Address

杭州市西湖区花牌楼160号

Empowering clinical research with data-driven insights and AI-powered tools.

注射用胸腺肽 - NMPA 批准文号 | MedPath